Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Orthofix Medical Inc. - Common Stock (NQ:OFIX)

14.54 -1.00 (-6.44%)
Streaming Delayed Price Updated: 2:54 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orthofix Medical Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
US Stocks Open Lower, Dow Falls 100 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday. 
Via Benzinga
Orthofix-SeaSpine to Combine Creating Leading Spine & Orthopedics Company
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers DICE Therapeutics (NASDAQ:DICE) stock moved upwards by 83.4% to $45.2 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.7 billion. 
Via Benzinga
OFIX STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Orthofix Medical Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results
From Orthofix Medical Inc.
Via Business Wire
Recap: Orthofix Medical Q1 Earnings
Orthofix Medical (NASDAQ:OFIX) reported its Q1 earnings results on Friday, May 6, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company
From Orthofix Medical Inc.
Via Business Wire
Orthofix Announces Presentation of Long-Term Evidence Highlighting the Clinical Management of Cervical Disc Arthroplasty at North American Spine Society Annual Meeting
From Orthofix Medical Inc.
Via Business Wire
Orthofix Medical Announces Participation in Upcoming Sidoti Virtual Investor Conference
From Orthofix Medical Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 250 stocks hit new 52-week lows. 
Via Benzinga
Orthofix Medical's Return On Capital Employed Overview
According to Benzinga Pro, during Q2, Orthofix Medical (NASDAQ:OFIX) earned $2.49 million, a 155.81% increase from the preceding quarter. Orthofix Medical also posted a total of $118.07 million in... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 73 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 15 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 72 companies set new 52-week lows. 
Via Benzinga
Recap: Orthofix Medical Q2 Earnings
  Orthofix Medical (NASDAQ:OFIX) reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Orthofix Reports Second Quarter 2022 Results
From Orthofix Medical Inc.
Via Business Wire
Earnings Scheduled For August 5, 2022
Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million. 
Via Benzinga
Orthofix Medical Earnings Preview
Orthofix Medical (NASDAQ:OFIX) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Orthofix... 
Via Benzinga
Orthofix Medical and CGBio Announce Strategic Partnership Agreement for Novosis rhBMP-2 Bone Graft Solutions
From Orthofix Medical Inc.
Via Business Wire
Orthofix Medical Schedules Second Quarter Earnings Release and Conference Call for August 5, 2022
From Orthofix Medical Inc.
Via Business Wire
Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
From Orthofix Medical Inc.
Via Business Wire
Orthofix Medical and LimaCorporate Announce Partnership to Provide Solution for Patients with High Hip Dislocation for the US Market
From Orthofix Medical Inc.
Via Business Wire
Looking Into Orthofix Medical's Return On Invested Capital
According to Benzinga Pro data, during Q1, Orthofix Medical (NASDAQ:OFIX) posted sales of $106.42 million. Earnings were up 86.41%, but Orthofix Medical still reported an overall loss of $4.46... 
Via Benzinga
Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years
From Orthofix Medical Inc.
Via Business Wire
Orthofix Medical Announces Participation in Upcoming UBS Global Healthcare Conference
From Orthofix Medical Inc.
Via Business Wire
Orthofix Reports First Quarter 2022 Results
From Orthofix Medical Inc.
Via Business Wire
Earnings Outlook For Orthofix Medical
Orthofix Medical (NASDAQ:OFIX) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Orthofix... 
Via Benzinga
FDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy Solutions
From Orthofix Medical Inc.
Via Business Wire
Earnings Scheduled For May 6, 2022
Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion. 
Via Benzinga
Orthofix and MTF Biologics Expand Partnership Agreement
From Orthofix Medical Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback